NCT00573495View on ClinicalTrials.gov

Multipeptide Vaccine for Advanced Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

February 28, 2013

Conditions
Breast NeoplasmBreast CancerCancer of the BreastCarcinoma, Ductal
Interventions
BIOLOGICAL

hTERT/Survivin Multi-Peptide Vaccine

100 mcg subcutaneous every 2 weeks four times, then monthly up to 28 vaccinations

Trial Locations (1)

19341

University of Pennsylvania Medical Center, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT00573495 - Multipeptide Vaccine for Advanced Breast Cancer | Biotech Hunter | Biotech Hunter